Benzinga | Oct 26, 2020 08:41AM EDT

Citius Pharmaceutics Expects Mini-Lok Phase 3 Trial Will Continued As Planned Until It Is Fully Enrolled, Expect To Be In First Half Of 2021

-SEC Filing